Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Efficacy and safety of switching from dupilumab to upadacitinib versus continuous upadacitinib in moderate-to-severe atopic dermatitis: Results from an open-label extension of the phase 3, randomized, controlled trial (Heads Up)
Andrew Blauvelt, Barry Ladizinski, Vimal H. Prajapati, Vivian T. Laquer, Alison Fischer, Samantha Eisman and 8 more
- Rank
- 13 of 1,810
- Percentile
- top 0.8%
- Where
- Journal of the American Academy of Dermatology, 2023
- Citations
- 54
From the 2023 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.